Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement Of Cash Flows [Abstract]
Net income (loss)	$ 479	$ (918)	$ (3,766)
Adjustments to reconcile net loss to net cash from operating activities:
Provision for loan losses	278	496	1,129
Provision for losses on foreclosed assets			962
Valuation (gain) loss on mortgage servicing rights			(1)
Depreciation	232	205	237
Amortization, net	189	437	673
Net gains on sales of securitites			(143)
Originations of loans held for sale	(50,140)	(32,603)	(30,461)
Proceeds from sale of loans held for sale	50,456	30,028	31,342
Net gains on sales of loans	(536)	(88)	(404)
(Gain) loss on disposal of premises and equipment		(1,114)	4
Gain on sale of foreclosed assets		(28)	(338)
Earnings on bank owned life insurance	(130)	(130)	(132)
Stock-based compensation expense	265	159	11
Net change in:
Accrued interest receivable and other assets	(240)	(409)	(215)
Accrued interest payable and other liabilities	202	(169)	142
Net cash from (used by) operating activities	1,055	(4,134)	(960)
Cash flows from investing activities
Net (increase) decrease in interest-bearing deposits in other financial institutions	1,488	744	(742)
Available-for-sale securities:
Sales			2,144
Maturities, prepayments and calls	4,073	7,690	11,497
Purchases	(5,019)		(13,447)
Loan originations and payments, net	(50,998)	(54,900)	(4,485)
Additions to premises and equipment	(461)	(341)	(24)
Proceeds from the sale of assets held for sale		3,187
Proceeds from the sale of foreclosed assets		149	1,720
Proceeds from mortgage insurance on foreclosed assets		14	73
Net cash from (used by) investing activities	(50,917)	(43,457)	(3,264)
Cash flows from financing activities
Net change in deposits	49,973	34,750	(43,621)
Net change in short-term borrowings from the FHLB and other debt	(6,526)	6,526
Proceeds from long-term FHLB advances and other debt	22,500
Repayments on long-term FHLB advances and other debt	(18,000)		(5,742)
Net change in advances by borrowers for taxes and insurance	(174)	334	82
Cash dividends paid on Series B preferred stock	(233)
Net proceeds from issuance of Series B preferred stock	11,369
Redemption of TARP obligations			(3,000)
Proceeds from sale of common stock			20,221
Cost associated with issuance of common stock		(11)
Net cash from (used by) financing activities	58,909	41,599	(32,060)
Net change in cash and cash equivalents	9,047	(5,992)	(36,284)
Beginning cash and cash equivalents	19,160	25,152	61,436
Ending cash and cash equivalents	28,207	19,160	25,152
Supplemental cash flow information:
Interest paid	2,097	1,956	2,835
Supplemental noncash disclosures:
Transfers from loans to repossessed assets		246	1,754
Loans issued to finance the sale of repossessed assets			171
Loans transferred from held for sale to portfolio			109
Transfer from premises and equipment to assets held for sale		$ 1,903